Home > Insider Trading > Filing (0001179110-13-009876)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Synta Pharmaceuticals Corp	SNTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1325719	R Safi Bahcall	C/O Synta Pharmaceuticals Corp. 45 Hartwell Avenue Lexington MA 02421	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-06	10,000	$4.04	1,993,135	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	15,000	Indirect	By Safi R. Bahcall Irrevocable Trust
Common Stock	65,000	Indirect	By Neta Bahcall 2012 Irrevocable Trust
Common Stock	400,000	Indirect	By Princeton GRAT

Footnotes

The shares were purchased in multiple transactions at prices ranging from $4.03 to $4.04 per share. The price reported above is the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.
Reflects the transfer of 400,000 shares on May 30, 2013 from Dr. Bahcall to a grantor retained annuity trust.
The Reporting Person disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.